1. Home
  2. ARMP vs DPRO Comparison

ARMP vs DPRO Comparison

Compare ARMP & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

SELL

Current Price

$3.02

Market Cap

199.7M

Sector

Health Care

ML Signal

SELL

Logo Draganfly Inc.

DPRO

Draganfly Inc.

HOLD

Current Price

$1.86

Market Cap

73.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
DPRO
Founded
N/A
1998
Country
United States
Canada
Employees
N/A
69
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
73.2M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
ARMP
DPRO
Price
$3.02
$1.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
★ $17.50
$9.60
AVG Volume (30 Days)
75.7K
★ 759.3K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$83.72
Revenue Next Year
N/A
$138.54
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$1.99
52 Week High
$14.98
$10.62

Technical Indicators

Market Signals
Indicator
ARMP
DPRO
Relative Strength Index (RSI) 46.59 21.01
Support Level $2.77 N/A
Resistance Level $3.96 $5.77
Average True Range (ATR) 0.44 0.27
MACD -0.02 -0.07
Stochastic Oscillator 43.35 2.76

Price Performance

Historical Comparison
ARMP
DPRO

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The two segments are Drones, and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: